Cargando…
Cell-permeable transgelin-2 as a potent therapeutic for dendritic cell-based cancer immunotherapy
BACKGROUND: Transgelin-2 is a 22 kDa actin-binding protein that has been proposed to act as an oncogenic factor, capable of contributing to tumorigenesis in a wide range of human malignancies. However, little is known whether this tiny protein also plays an important role in immunity, thereby keepin...
Autores principales: | Kim, Hye-Ran, Park, Jeong-Su, Park, Jin-Hwa, Yasmin, Fatima, Kim, Chang-Hyun, Oh, Se Kyu, Chung, Ik-Joo, Jun, Chang-Duk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968273/ https://www.ncbi.nlm.nih.gov/pubmed/33731208 http://dx.doi.org/10.1186/s13045-021-01058-6 |
Ejemplares similares
-
Transgelin-2: A Double-Edged Sword in Immunity and Cancer Metastasis
por: Kim, Hye-Ran, et al.
Publicado: (2021) -
Transgelin-2 in B-Cells Controls T-Cell Activation by Stabilizing T Cell - B Cell Conjugates
por: Na, Bo-Ra, et al.
Publicado: (2016) -
Label-free quantitative phosphorylation analysis of human transgelin2 in Jurkat T cells reveals distinct phosphorylation patterns under PKA and PKC activation conditions
por: Jang, Se Hwan, et al.
Publicado: (2015) -
Potentiating the Antitumor Activity of Cytotoxic T Cells via the Transmembrane Domain of IGSF4 That Increases TCR Avidity
por: Kim, Hye-Ran, et al.
Publicado: (2021) -
The Immunosuppressive Potential of Cholesterol Sulfate Through T Cell Microvilli Disruption
por: Park, Jeong-Su, et al.
Publicado: (2023)